TradingAgents AISign inGet started
All stock profiles
HIMSNYSEConsumer Defensive

HIMS & HERS HEALTH INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$26.00

+8.06%

Alpha Vantage · 11/6/2026

Industry: Household & Personal ProductsCategory: Domestic Common Stock Primary ClassCurrency: USDNews: 1 recent
Analyze HIMS free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

-7.3%

3 months

-18.2%

6 months

-8.0%

1 year

-37.4%

Year to date

-19.9%

52-week range

$14.52 – $41.52

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$6.07B

P/E

-42.7

P/B

18.7

P/S

2.4

Revenue

$2.58B

Net income

-$142.03M

Diluted EPS

-0.63

Gross margin

68.40%

Net margin

-5.50%

Return on equity

-30.00%

Total debt

$1.55B

Cash

$609.81M

Free cash flow

$61.63M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$753.21M-$86.29M63.80%-11.50%-$68.19M
Mar 31, 2026$608.1M-$92.12M65.20%-15.10%$53.03M
Dec 31, 2025$617.82M$20.6M71.90%3.30%-$2.57M
Sep 30, 2025$598.98M$15.77M73.80%2.60%$79.36M
Jun 30, 2025$544.83M$42.51M76.40%7.80%-$69.43M
Mar 31, 2025$586.01M$49.49M73.50%8.40%$50.05M
Dec 31, 2024$481.14M$26.03M76.80%5.40%$59.5M
Sep 30, 2024$401.56M$75.59M79.20%18.80%$79.39M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent HIMS news

All market news
Business Wire·79 signal
Hims & Hers Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Kahn Swick & Foti, LLC (KSF) is reminding investors of Hims & Hers Health, Inc. (NYSE: HIMS) with losses over $100,000 that they have until November 2, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Hims & Hers Health and its executives failed to disclose material information regarding the sharing of sensitive health data and deceptive billing practices, which led to a significant drop in stock price after an FTC announcement on July 29, 2026. KSF is encouraging affected investors to contact them to discuss their legal rights and potential recovery.

Original source